Research!America and the Congressional R&D Caucus will host a congressional briefing, Medical Innovation 101, on February 14 in the Rayburn House Office building on Capitol Hill. A panel of experts will demystify the process behind medical and health progress, tracing the path from bench to bedside and discussing key variables that will affect efforts to overcome deadly and disabling diseases. Discussion will touch on economic impact, R&D and how various aspects of the research ecosystem works together under the common goal of seeking life-saving treatments. The panel will be moderated by Eleanor M. Perfetto, Ph.D., M.S., senior vice president of strategic initiatives, National Health Council.
Speakers include Keith R. Yamamoto, Ph.D., vice chancellor for science policy and strategy; director, UCSF Precision Medicine; vice dean for research, School of Medicine; Professor, Cellular & Molecular Pharmacology, University of California, San Francisco; Brian Gill, vice president of corporate affairs, Celgene; Joe V. Selby, M.D., MPH, executive director, Patient-Centered Outcomes Research Institute (PCORI); and John E. Schneider, Ph.D., CEO, Avalon Health Economics LLC. The panel was made possible in part by support from Eli Lilly and Company.
For more information and to register, click here.